JP2010524894A5 - - Google Patents

Download PDF

Info

Publication number
JP2010524894A5
JP2010524894A5 JP2010503511A JP2010503511A JP2010524894A5 JP 2010524894 A5 JP2010524894 A5 JP 2010524894A5 JP 2010503511 A JP2010503511 A JP 2010503511A JP 2010503511 A JP2010503511 A JP 2010503511A JP 2010524894 A5 JP2010524894 A5 JP 2010524894A5
Authority
JP
Japan
Prior art keywords
alkyl
phenyl
optionally substituted
carbocyclyl
halogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2010503511A
Other languages
English (en)
Japanese (ja)
Other versions
JP5675341B2 (ja
JP2010524894A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2008/054711 external-priority patent/WO2008128982A1/en
Publication of JP2010524894A publication Critical patent/JP2010524894A/ja
Publication of JP2010524894A5 publication Critical patent/JP2010524894A5/ja
Application granted granted Critical
Publication of JP5675341B2 publication Critical patent/JP5675341B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2010503511A 2007-04-18 2008-04-18 グルタミニルシクラーゼ阻害剤としてのチオキソキナゾリノン誘導体 Expired - Fee Related JP5675341B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US91254007P 2007-04-18 2007-04-18
US60/912,540 2007-04-18
PCT/EP2008/054711 WO2008128982A1 (en) 2007-04-18 2008-04-18 Thioxoquinazolinone derivatives as glutaminyl cyclase inhibitors

Publications (3)

Publication Number Publication Date
JP2010524894A JP2010524894A (ja) 2010-07-22
JP2010524894A5 true JP2010524894A5 (OSRAM) 2011-09-08
JP5675341B2 JP5675341B2 (ja) 2015-02-25

Family

ID=39684456

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010503511A Expired - Fee Related JP5675341B2 (ja) 2007-04-18 2008-04-18 グルタミニルシクラーゼ阻害剤としてのチオキソキナゾリノン誘導体

Country Status (6)

Country Link
US (1) US9034907B2 (OSRAM)
EP (1) EP2160389B1 (OSRAM)
JP (1) JP5675341B2 (OSRAM)
DK (1) DK2160389T3 (OSRAM)
ES (1) ES2478673T3 (OSRAM)
WO (1) WO2008128982A1 (OSRAM)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7732162B2 (en) * 2003-05-05 2010-06-08 Probiodrug Ag Inhibitors of glutaminyl cyclase for treating neurodegenerative diseases
JP5676249B2 (ja) * 2007-04-20 2015-02-25 プロビオドルグ エージー グルタミニルシクラーゼ阻害剤としてのアミノピリジン誘導体
JP2011501652A (ja) * 2007-09-12 2011-01-13 プロビオドルグ エージー トランスジェニックマウス
EP2238252B1 (en) * 2008-01-14 2013-07-31 Probiodrug AG Mouse models carrying a knock-out mutation of the glutaminyl cyclase gene
CN105481980A (zh) 2008-07-21 2016-04-13 前体生物药物股份公司 诊断抗体测定
AU2010232923A1 (en) * 2009-04-03 2011-11-03 Medisyn Technologies, Inc. Compositions for treatment of Alzheimer's disease
CN102695546B (zh) 2009-09-11 2014-09-10 前体生物药物股份公司 作为谷氨酰胺酰环化酶抑制剂的杂环衍生物
US20110152341A1 (en) 2009-12-22 2011-06-23 Probiodrug Ag Cleavage of b-amyloid precursor protein
CN102947705A (zh) 2010-02-18 2013-02-27 前体生物药物股份公司 通过确定焦谷氨酸修饰的mcp-1诊断炎性疾病的方法和谷氨酰胺酰基环化酶抑制剂的筛选方法
EP2886120B1 (en) * 2010-10-29 2019-06-19 Emory University Quinazoline derivatives, compositions and uses related thereto
AU2012228236B2 (en) 2011-03-16 2016-10-27 Vivoryon Therapeutics N.V. Diagnostic antibody assay
US20150110723A1 (en) * 2012-05-31 2015-04-23 Emory University Quinazoline derivatives, compositions, and uses related thereto
JP2018501482A (ja) 2014-12-19 2018-01-18 プロビオドルグ エージー pGlu−Abetaペプチドの検出のための新規の方法
ES2950348T3 (es) 2015-12-09 2023-10-09 Novartis Ag Moduladores de receptores NMDA de tienopirimidinona y usos de los mismos
LT3386591T (lt) 2015-12-09 2020-10-12 Cadent Therapeutics, Inc. Heteroaromatiniai nmda receptoriaus moduliatoriai ir jų panaudojimas
US11274107B2 (en) 2016-12-22 2022-03-15 Cadent Therapeutics, Inc. NMDA receptor modulators and uses thereof
PL3461819T3 (pl) 2017-09-29 2020-11-30 Probiodrug Ag Inhibitory cyklazy glutaminylowej
EP3521308B1 (en) 2018-01-31 2024-03-13 Vivoryon Therapeutics N.V. Humanized and de-immunized antibodies
JP7319369B2 (ja) 2018-08-03 2023-08-01 ノバルティス アーゲー ヘテロ芳香族nmda受容体モジュレーターおよびその使用

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4684654A (en) 1985-08-14 1987-08-04 American Cyanamid Company 3-heteroalkyl-2,4-quinzaolinediones
EP0293500A1 (en) 1987-06-01 1988-12-07 American Cyanamid Company 3-heteroalkyl-2,4.quinzaoline-diones
US6948038B2 (en) * 2001-07-24 2005-09-20 Microsoft Corporation System and method for backing up and restoring data
WO2003053958A1 (en) * 2001-12-20 2003-07-03 Celltech R & D Limited Quinazolinedione derivatives
US7732162B2 (en) 2003-05-05 2010-06-08 Probiodrug Ag Inhibitors of glutaminyl cyclase for treating neurodegenerative diseases
US8338120B2 (en) 2003-05-05 2012-12-25 Probiodrug Ag Method of treating inflammation with glutaminyl cyclase inhibitors
US7371871B2 (en) 2003-05-05 2008-05-13 Probiodrug Ag Inhibitors of glutaminyl cyclase
KR20110059664A (ko) 2003-05-05 2011-06-02 프로비오드룩 아게 글루타미닐 및 글루타메이트 사이클라제의 이펙터의 용도
CN1867324A (zh) 2003-10-15 2006-11-22 前体生物药物股份公司 谷氨酰胺酰基环化酶效应物和谷氨酸环化酶效应物的应用
WO2005049027A2 (en) 2003-11-03 2005-06-02 Probiodrug Ag Combinations useful for the treatment of neuronal disorders
US20050171112A1 (en) 2003-11-03 2005-08-04 Probiodrug Ag Combinations useful for the treatment of neuronal disorders
US7667044B2 (en) 2003-11-03 2010-02-23 Probiodrug Ag Compounds for the treatment of neurological disorders
BRPI0507485A (pt) 2004-02-05 2007-07-10 Probiodrug Ag inibidores novos de glutaminil ciclase
NZ575727A (en) 2006-09-21 2011-12-22 Probiodrug Ag Novel genes related to glutaminyl cyclase
US8420684B2 (en) 2006-11-09 2013-04-16 Probiodrug Ag Inhibitors of glutaminyl cyclase
JP5599614B2 (ja) 2006-11-09 2014-10-01 プロビオドルグ エージー グルタミニルシクラーゼの新規阻害剤
ATE554085T1 (de) 2006-11-30 2012-05-15 Probiodrug Ag Neue inhibitoren von glutaminylcyclase
US20080200567A1 (en) 2007-01-19 2008-08-21 Probiodrug Ag In vivo screening models for treatment of alzheimer's disease and other qpct-related disorders
US7803810B2 (en) 2007-03-09 2010-09-28 Probiodrug Ag Inhibitors

Similar Documents

Publication Publication Date Title
JP2010524894A5 (OSRAM)
HRP20191102T1 (hr) Sintetski međuprodukti za pripravu konjugata oligosaharid-protein
HUE042847T2 (hu) A 44 xiloglukanáz család egyik variánsát tartalmazó felületaktív készítmény
EP2181399A4 (en) COMPOSITE STUFFED FLOWS
EP2213856A4 (en) AUSPUFFROHR
JP2010512298A5 (OSRAM)
EP2215068A4 (en) ANTIDIABETIC TRICYCLIC COMPOUNDS
DK3061467T3 (da) Sårforbinding med en bakterieadsorberende sammensætning
BRPI0922904A2 (pt) "compostos"
SE0601145L (sv) Vakuumöppningar av höghastighetstyp
BRPI0923786A2 (pt) compostos 5,6-dihidro-6-fenilbenzo(f) isoquinolina-2- amina substituidos
JP2010504301A5 (OSRAM)
EP2491025A4 (en) AZAAZULENVERBINDUNGEN
JP2011510079A5 (OSRAM)
EP2307421A4 (en) oxindole
EP2117306A4 (en) NEUROGENIC COMPOUNDS
DK1776090T3 (da) Stabiliseret prostaglandinsammensætning
JP2011037885A5 (OSRAM)
DE502005005800D1 (de) Selbsteinstellendes Gleitstück für Teleskopkranausleger
FI20075529A0 (fi) Nostokoukku
EP1960358A4 (en) ANTINEOPLASTIC COMPOUNDS
JP2013512203A5 (OSRAM)
EP2308860A4 (en) BASED ON THE INTERRUPTION OF THE TCR-NCK INTERACTION IMMUNOSUPPRESSOR
EP1759410A4 (en) Organotinic precursor compositions
ITTO20080025A1 (it) Attrezzatura per l'esecuzione di fori secanti.